Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Dynavax Stock Zoomed Higher Today


Dynavax Technologies (NASDAQ: DVAX), a biotech considered by some to be a coronavirus stock, outpaced the broader market on Wednesday. The company's shares rose by 5.6%, on the back of a significant price-target increase from an analyst.

That analyst is Edward White of H.C. Wainwright, who this morning lifted his price target on the stock to $28 from the previous $23, while maintaining his buy recommendation.

Image source: Getty Images.

Continue reading


Source Fool.com

Like: 0
Share

Comments